Germany's national public health gets reorganized: A new institute shall take center stage

IF 3.6 3区医学 Q1 HEALTH CARE SCIENCES & SERVICES

Health Policy Pub Date : 2024-05-24 DOI:10.1016/j.healthpol.2024.105084

Nicolai Savaskan , Benedikt M.J. Lampl , Mesut Yavuz , Peter Tinnemann

{"title":"Germany's national public health gets reorganized: A new institute shall take center stage","authors":"Nicolai Savaskan , Benedikt M.J. Lampl , Mesut Yavuz , Peter Tinnemann","doi":"10.1016/j.healthpol.2024.105084","DOIUrl":null,"url":null,"abstract":"<div><p>In the aftermath of the COVID-19 pandemic, the German federal government recently orchestrated a fundamental change to its public health infrastructure. This reconstruction centers around the founding of a National Institute for Prevention and Education in Medicine (Bundesinstitut für Prävention und Aufklärung in der Medizin, BIPAM) at the cost of two federal institutions, the Robert Koch-Institute (RKI) and the Federal Center for Health Education (Bundeszentrale für gesundheitliche Aufklärung, BzGA). Thus, the Federal Ministry of Health (Bundesministerium für Gesundheit, BMG) plans to dissolve the BzGA and integrate its personnel into the future BIPAM. Further, all RKI research and surveillance activities related to non-communicable diseases, including AI methods development will be transferred into the BIPAM. The RKI responsibilities will solely focus on infectious diseases. According to announced plans of the BMG the primary objective for establishing the BIPAM is to address non-communicable diseases and enhance overall population health. However, the medical specialist training for public health remains non-academic at a state institution. Simultaneously the BMG already replaced two thirds of experts of the permanent commission on vaccination (Ständige Impfkommission, STIKO) and determined new procedures for appointing future expert commissioners. With these changes, Germany embarks on an extraordinary reshuffling of its national public health organizations and responsibilities, by fundamentally separating all issues around non-communicable diseases from those of infectious diseases. Germany's unraveled research tasks of public health authorities however remains unmet. Thus, 2024 marks a pivotal caesura for public health in the modern history of Germany.</p></div>","PeriodicalId":55067,"journal":{"name":"Health Policy","volume":"145 ","pages":"Article 105084"},"PeriodicalIF":3.6000,"publicationDate":"2024-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Policy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0168851024000940","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}

引用次数: 0

Abstract

In the aftermath of the COVID-19 pandemic, the German federal government recently orchestrated a fundamental change to its public health infrastructure. This reconstruction centers around the founding of a National Institute for Prevention and Education in Medicine (Bundesinstitut für Prävention und Aufklärung in der Medizin, BIPAM) at the cost of two federal institutions, the Robert Koch-Institute (RKI) and the Federal Center for Health Education (Bundeszentrale für gesundheitliche Aufklärung, BzGA). Thus, the Federal Ministry of Health (Bundesministerium für Gesundheit, BMG) plans to dissolve the BzGA and integrate its personnel into the future BIPAM. Further, all RKI research and surveillance activities related to non-communicable diseases, including AI methods development will be transferred into the BIPAM. The RKI responsibilities will solely focus on infectious diseases. According to announced plans of the BMG the primary objective for establishing the BIPAM is to address non-communicable diseases and enhance overall population health. However, the medical specialist training for public health remains non-academic at a state institution. Simultaneously the BMG already replaced two thirds of experts of the permanent commission on vaccination (Ständige Impfkommission, STIKO) and determined new procedures for appointing future expert commissioners. With these changes, Germany embarks on an extraordinary reshuffling of its national public health organizations and responsibilities, by fundamentally separating all issues around non-communicable diseases from those of infectious diseases. Germany's unraveled research tasks of public health authorities however remains unmet. Thus, 2024 marks a pivotal caesura for public health in the modern history of Germany.

查看原文本刊更多论文

德国国家公共卫生机构重组：一个新机构成为中心舞台

COVID-19 大流行之后，德国联邦政府最近对其公共卫生基础设施进行了根本性改革。这次重建的核心是成立国家医学预防和教育研究所（Bundesinstitut für Prävention und Aufklärung in der Medizin, BIPAM），由罗伯特-科赫研究所（Robert Koch-Institute, RKI）和联邦健康教育中心（Bundeszentrale für gesundheitliche Aufklärung,BzGA）这两个联邦机构出资。因此，联邦卫生部（BMG）计划解散 BzGA，并将其人员纳入未来的 BIPAM。此外，所有与非传染性疾病相关的 RKI 研究和监测活动，包括人工智能方法的开发，都将移交给 BIPAM。RKI 的职责将完全集中在传染病方面。根据 BMG 公布的计划，建立 BIPAM 的主要目标是应对非传染性疾病和提高整体人口健康水平。然而，公共卫生方面的医学专家培训仍然是在国立机构进行的非学术性培训。与此同时，BMG 已经更换了疫苗接种常设委员会（Ständige Impfkommission, STIKO）三分之二的专家，并确定了任命未来专家委员的新程序。随着这些变化，德国开始对其国家公共卫生组织和职责进行非同寻常的调整，从根本上将所有与非传染性疾病有关的问题与传染性疾病问题分开。然而，德国公共卫生机构尚未完成的研究任务仍未完成。因此，2024 年标志着德国现代史上公共卫生领域的一个关键转折点。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Health Policy 医学-卫生保健

CiteScore

6.40

自引率

6.10%

发文量

157

审稿时长

3-8 weeks

期刊介绍： Health Policy is intended to be a vehicle for the exploration and discussion of health policy and health system issues and is aimed in particular at enhancing communication between health policy and system researchers, legislators, decision-makers and professionals concerned with developing, implementing, and analysing health policy, health systems and health care reforms, primarily in high-income countries outside the U.S.A.